ADCYAP1 and cardiomyopathy: Several research groups have reported that endo- and exogenous PACAP prevents several types of organ injuries, including neuronal injuries [14,15,16,17], cardiomyopathy [18,19], hepatic damages [13,20,21], renal failure [13,22], and systemic inflammation [23].